Vol.

No.

October 29, 2021Oct 29, 2021

DOWNLOAD THE PDF

Eric Winer talks about his vision for Yale Cancer Center—and his return to New Haven

Cover Story

Conversation with The Cancer Letter

Eric Winer talks about his vision for Yale Cancer Center—and his return to New Haven

By Paul Goldberg

Eric P. Winer will begin his job as director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital at Yale on Feb. 1, but he has started his “listening tour” early.

Conversation with The Cancer Letter

Danny Milner: mRNA vaccines may become a viable treatment for cancer because of COVID-19 pandemic

By Alice Tracey

Guest Editorial

Jill Biden’s visit to Hollings brings awareness to mammograms missed during the pandemic

By Raymond N. DuBois

Free In the Archives

Funding cancer research in the Great Depression: “wheedle, coax, and threaten”
Ned Sharpless to deliver Paul Calabresi Memorial Lecture, Nov. 2

Clinical Trials & Tribulations

Removing barriers to cancer care in underserved communities

By Dany Habr

In Brief

Lurie Cancer Center receives $12.6M merit extension from NCI

Annual Report to the Nation: Patient economic burden of cancer care over $21B

Colleen Lawton and Lori Pierce awarded ASTRO Gold Medal

Roswell Park’s Department of Pathology & Laboratory Medicine reports six promotions, one new appointment

USC Norris establishes survivorship program focused on residual breast cancer

Clinical Roundup

ACCC project supports quality care for stage III and IV NSCLC

NCCN, Polish health leaders publish consensus guidelines on cervical cancer

Serial radiation therapy is safe and effective as alternative treatment to systemic therapy for RCC

External-beam radiation therapy underused for people with liver cancer awaiting transplant

Shortened course of radiation therapy offers similar long-term side effects following prostate removal surgery

Intervention eliminates Black-white gaps in survival from early-stage breast and lung cancer

Genetic biomarker test predicts recurrence and survival outcomes for men with high-risk prostate cancer

SBRT thwarts tumor growth in patients with advanced lung cancer

Prior authorization costs radiation oncology clinics more than $40 million each year, study estimates

TRACERx study validates use of liquid biopsy for personalized cancer treatment

Drugs & Targets

FDA’s new web pages track accelerated approvals in oncology

Kymriah granted FDA priority review and EMA filing acceptance

Morphogenesis receives FDA ‘fast track’ designation for skin cancer vaccine

FDA strengthens breast implant safety requirements

Foundation Medicine now an in-network provider for Humana Military and Health Net Federal Services

Citius acquires license for late-phase III oncology immunotherapy for cutaneous T-cell lymphoma

Cardinal Health receives $750,000 FDA grant to study oncology trial designs by comparing RWE to RCT results

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 33 - September 06, 2024